Throughout the month of September, in recognition of the American Medical Association’s (AMA) Women in Medicine Month, CU Anschutz News is recognizing a few of the extraordinary women who work in all aspects of the medical field on this campus. They share the significance of being a woman in medicine and the challenges of fulfilling their numerous roles during a worldwide pandemic. Brigadier General Kathleen Flarity is highlighted in the launch of the series.
Leaders at the Colorado health system have expanded their Virtual Health Center concept to facilitate a sepsis early-warning system that is improving patient outcomes--and they are our number-one winning Innovator Awards team. (Author: David Raths)
Dr. Bebarta was awarded a highly competitive NIH R21 research grant to study the use of thiosulfate for chlorine gas exposures, which can cause deadly respiratory symptoms in military or industrial exposures.
Recent work by Dr. Ginde and colleagues from the CDC's IVY Network demonstrates the sustained effectiveness of mRNA vaccines against severe outcomes from COVID-19, including hospitalization. The data, which includes some time in which the Delta variant was dominant, were featured in a White House press conference with Surgeon General Murthy, CDC Director Walensky, and White House Health Advisor Fauci.
Dr. Ginde's Early Critical Care Trials Group was a core contributor to research recently published in the Journal Clinical Infectious Diseases demonstrating the effectiveness of COVID vaccines in the early phases of the pandemic.